Brain scan patterns may help predict if brain tumors grow
Original title: MRI-based intratumoral and peritumoral heterogeneity for predicting intracranial progression in EGFR-mutant lung adenocarcinoma patients with treatment-naive brain metastases receiving first-line third-generation EGFR-TKIs.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This was a look back at past scans in people, and the tool is not used in clinics yet.
The short version
Doctors used brain scans to help tell which brain tumors would grow sooner.
What was studied. Researchers looked back at records of 141 people. They had lung cancer with an EGFR gene change that had spread to the brain. All took a newer EGFR pill as their first treatment. The team studied MRI scans taken before treatment started.
What they found. Of the 141 people, 75 had cancer that grew and 66 did not. The team built a computer model from the scan patterns plus patient details. It looked at the tumor and a 6-mm band of tissue around it. The model was right about 76.5% of the time. People it marked as high risk had less time before the brain cancer grew.
What this means, and what it doesn't
What it could mean: This is a research tool, not a treatment. If it holds up, doctors could use regular MRI scans to spot higher risk. That might mean closer checkups for some people. It would not change the drug you take.
What it doesn't mean: This does not mean a new treatment, and it is not a cure. The team looked back at old records instead of running a trial. The tool is still being built and tested. It is not used in clinics, and you cannot ask for it today. It also cannot tell any one person what will happen.
Source: PubMed, October 17, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.